Dexibuprofen

DRUG5 trials

Sponsors

Cannaxan GmbH, Apurano Pharmaceuticals GmbH, Inje University, Gebro Pharma GmbH, Apsen Farmaceutica S.A.

Conditions

Chronic back painFeverHealthy VolunteersOsteoarthritis of the Hip or KneeRespiratory Tract Infection

Phase 1

Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions

CompletedNCT02956512

Apsen Farmaceutica S.A.Healthy Volunteers

Start: 2019-03-18End: 2019-09-06Updated: 2020-11-18

Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions

CompletedNCT02956525

Apsen Farmaceutica S.A.Healthy Volunteers

Start: 2018-04-01End: 2018-07-01Updated: 2023-02-09

Phase 3

The Efficacy and Safety of Dexibuprofen Syrup

CompletedNCT00812422

Inje UniversityFever, Respiratory Tract Infection

Start: 2008-02-29End: 2009-05-31Updated: 2010-01-18

Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain

SuspendedCTIS2022-502151-54-00

Cannaxan GmbH, Apurano Pharmaceuticals GmbHChronic back pain

Start: 2023-11-02Target: 558Updated: 2024-11-22

Phase 4

Dexibuprofen 400 mg Sachet Versus Ibuprofen 400 mg Sachet in Patients With Osteoarthritis of the Hip or Knee

CompletedNCT01066676

Gebro Pharma GmbHOsteoarthritis of the Hip or Knee

Start: 2009-10-31End: 2012-06-30Updated: 2012-07-10